Campaign for Esophageal Cancer Research Funding
Over the past two years, more than $11 million in new federal funding has been awarded to Esophageal Cancer researchers [...]
Over the past two years, more than $11 million in new federal funding has been awarded to Esophageal Cancer researchers [...]
A side effect of some cancer treatments commonly referred to as “chemo brain” has received increasing attention from researchers lately. [...]
A new study from Great Britain underscores the importance of early detection of Barrett's Esophagus in the fight to stop [...]
Since March 2021, the U.S. Food and Drug Administration has issued four approvals for PD-L1 Inhibitors for patients with Esophageal [...]
The U.S. Food & Drug Administration has granted Priority Review for the use of immunotherapies in three new designations for [...]
The U.S. Food & Drug Administration has approved a new therapy for adult patients with locally advanced or metastatic HER2+ [...]
The latest statistics released by the American Cancer Society projects that fewer Americans will die of Esophageal Cancer in 2021 [...]
Findings of three studies important to Esophageal Cancer patients were presented at the 2020 ESMO (European Society of Medical Oncology) [...]
Results of a clinical study called PANGEA (Personalized ANtibodies for GastroEsophageal Adenocarcinoma) found survival benefits for patients when compared to [...]
The early results of two large, Phase III clinical trials of the immunotherapy Opdivo (nivolumab) showed significant survival benefits for [...]